Search Results 841-850 of 16705 for intermittent fasting optimization

1. Obesity - Doctors and departments - Mayo Clinic

   Eating problems after hiatal hernia & nissen fundoplication. 28 Replies Mon, Apr 13, 2026. brendanordstrom · Transoral outlet reduction (TORe) for severe ...

2. A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors - Mayo Clinic

   ... optimal dosages and risks/benefits. ... intermediate-2/high risk disease (Passamonti et ... o hemoglobin ≥9 g/dL. Phase 1b Expansion (Dose Optimization Part 4).

3. Short Bowel Syndrome and Teduglutide VS Placebo - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later phase (phase 3) ... diet soda. History of pancreatitis; Primary renal impairment (estimated GFR [eGFR] ...

4. A Study of the Efficacy of Lorcaserin for Weight Loss in Overweight Peri- and Postmenopausal Women - Mayo Clinic

   Have a known active eating disorder;; Have a known, active, untreated clinically significant psychiatric condition (alcohol or substance abuse, psychosis ...

5. Study of Levosimendan in Pulmonary Hypertension Patients with Heart Failure and Preserved Left Ventricular Ejection Fraction (PHHFpEF) - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... The purpose of this study is to evaluate the effectiveness and safety of intermittent ... optimize the patient.

6. Mayo Clinic

   afp-lindsay-lehman. Sections. Products and services. The Mayo Clinic Diet: What is your weight-loss goal? 5-10. Lindsey M. Lehman, M.H.A..

7. Fecal Microbiome Transplant National Registry - Mayo Clinic

   About this study. The overarching goal of the FMT registry is to expand knowledge and optimize practice in the transplantation of fecal microbiota or other ...

8. A Study to Evaluate the Effect of Metformin on Frailty in 12 Subjects (6 Metformin/6 Placebo in a Randomized Fashion) - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...

9. Study of LY2784544 Testing Alternative Dosing in Participants with Myeloproliferative Neoplasms - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers ... Have intermediate-1, intermediate-2, or high-risk MF according to the ...

10. A Study Measuring the Effectiveness of Simulated Preparation for Commonly Encountered Emotional, Cultural and Medical Difficulties in Global Health Experiences - Mayo Clinic

    The purpose of this study is to determine if SUGAR simulated training is effective in preparing individuals for the emotional, cultural and medical difficulties ...